openPR Logo
Press release

Erectile Dysfunction Treatment Devices Market Size will Observe Substantial Growth by 2025

06-19-2018 06:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

Erectile Dysfunction Treatment Devices Market Size will

Erectile dysfunction, also referred as impotence, is a medical condition that results in inability to get and keep erection firm during sexual intercourse. Several factors such as hormonal imbalance, insufficient blood flow to penis, conditions affecting the nervous system, and psychological causes such as depression and anxiety are the leading causes of erectile dysfunction. Erectile dysfunction may also be caused by underlying medical conditions such as high blood pressure and cardiovascular diseases. Technological advancement in the field of erectile dysfunction has led to the development of novel treatment devices such as external penile support devices, penile vibrators, and extracorporeal shockwave therapy.

The global Erectile Dysfunction Treatment Devices Market is projected to be primarily driven by the high prevalence and rising incidences of erectile dysfunction. Around 50% of men aged 40 to 70 years are estimated to suffer from some degree of erectile dysfunction. Incidence of erectile dysfunction increases with the growing age. This is projected to drive the erectile dysfunction treatment devices market during the forecast period. People with lifestyle related risk factors, especially chain smokers, are more susceptible to erectile dysfunction. Technological advancement has led to new product development with higher efficiency and high levels of satisfaction among users. New product development and approvals for erectile dysfunction treatment such as external penile support devices are estimated to fuel the erectile dysfunction treatment devices market during the forecast period. However, availability of therapeutic drugs and high cost of implantable devices is likely to restrain erectile dysfunction treatment devices market growth in the near future.

The global erectile dysfunction treatment devices market can be segmented based on product type, end-user, and geography. In terms of product type, the global erectile dysfunction treatment devices market can be divided into penile implants, external penile support devices, vacuum constriction devices, and erectile dysfunction shockwave generators. The penile implants segment is expected to account for significant share of the erectile dysfunction treatment devices market during the forecast period. Penile implants are surgical prosthetic devices that are implanted within erection chambers of penis. The penile implants segment can be further bifurcated into inflatable and malleable penile implants. Malleable implants consist of a set of two cylindrical rods (bendable enough) that is placed in the corpora of penis. Inflatable penile prosthesis consists of two cylindrical rods attached to reservoir and pump.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42131

These are surgically implanted into the lower abdomen. Around 80% to 90% men treated with inflatable penile prosthetic device have shown high levels of satisfaction. External support devices are newly invented devices for the treatment of erectile dysfunction. These are worn externally without any surgical interventions. These devices are developed to provide length and rigidity to penis and are worn during the sexual intercourse. Low intensity extracorporeal shockwave therapy is used in erectile dysfunction shockwave generators. This significantly improves the penile hemodynamics and is likely to induce structural changes to regenerate penile tissue. In terms of end-user, the erectile dysfunction treatment devices market can be segregated into hospitals, ambulatory surgery centers, and specialty clinics.

Based on geography, the global erectile dysfunction treatment devices market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to account for the leading share of the global erectile dysfunction treatment devices market during the forecast period. Currently, more than 18 million men in the U.S. are being affected by erectile dysfunction. This number is expected to rise over the years. Presence of well-established health care facilities, easy access to health care centers, easy availability of treatment devices, and favorable medical reimbursement policies for implantable penile prosthesis are some of the factors projected to drive the erectile dysfunction treatment devices market in North America & Europe during the forecast period. The erectile dysfunction treatment devices market in Asia Pacific is likely to expand at a fast-paced CAGR during the forecast period.

Key players operating in the global erectile dysfunction treatment devices market include Global Life Technologies, LLC, Coloplast Corp., The Elator, Tyna International Limited, Boston Scientific Corporation, Zephyr Surgical Implants, Promedon Group, STORZ MEDICAL AG, and Augusta Medical Systems.

View Report -

https://www.transparencymarketresearch.com/erectile-dysfunction-treatment-devices-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Treatment Devices Market Size will Observe Substantial Growth by 2025 here

News-ID: 1089189 • Views: 388

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Erectile

50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E …
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction Devices Market to Develop Rapidly by 2018 – 2026
Erectile Dysfunction Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Erectile Dysfunction Devices market research report is a professional and in-depth study on the current state of Erectile Dysfunction Devices Industry. The Erectile Dysfunction Devices Market research report covers the present scenario and
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Erectile Dysfunction - Pipeline Review, H2 2017”. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564 The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,